Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Vaccine|February 15, 2018
RTS,S malaria vaccine efficacy and immunogenicity during Plasmodium falciparum challenge is associated with HLA genotypeC M Nielsen, J Vekemans, M Lievens, et al.The American Journal of Physiology|February 1, 1996
Adenosine nucleotides in bileR S Chari, S M Schutz, J E Haebig, et al.The American Journal of Pathology|November 12, 1998
Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissuesA Jiménez-Huete, P M Lievens, R Vidal, et al.Gut|June 20, 2001
Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia: a multicentre database studyM B Wallace, V L Durkalski, J Vaughan, et al.The Biochemical Journal|December 1, 1996
Activation effects of a prion protein fragment [PrP-(106-126)] on human leucocytesL Diomede, S Sozzani, W Luini, et al.Vaccine|November 9, 2004
Safety and immunogenicity profile of an experimental hepatitis B vaccine adjuvanted with AS04G Boland, J Beran, M Lievens, et al.The Journal of Biological Chemistry|November 23, 2000
A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Sträussler-Scheinker disease A117VF Tagliavini, P M Lievens, C Tranchant, et al.Science (New York, N.Y.)|May 16, 1997
Effectiveness of anthracycline against experimental prion disease in Syrian hamstersF Tagliavini, R A McArthur, B Canciani, et al.Journal of Neuropathology and Experimental Neurology|October 24, 1998
Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneityP Piccardo, S R Dlouhy, P M Lievens, et al.The New England Journal of Medicine|October 22, 2015
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria VaccineD E Neafsey, M Juraska, T Bedford, et al.Pageof 3